60
Participants
Start Date
June 1, 2023
Primary Completion Date
January 31, 2025
Study Completion Date
August 31, 2025
ACEI, SGLT-2i
"Group 1 (ACEI group) will receive a single dose of oral ACE inhibitors tablets per day (0.2-0.6mg) /kg/ day)~❖ Group 2 (combined ACEI and SGLT-2inhibitrs group) patients on a single dose of oral ACE inhibitors tablets per day (0.2-0.6mg /kg/ day) presenting with persistent nephrotic range proteinuria will add a single dose of oral SGLT-2 inhibitors tablets 5mg per day (weight≤30kg) or 10mg per day (weight \>30kg)"
RECRUITING
Mansoura University Children's Hospital, Al Mansurah
Mansoura University
OTHER